BPC-157 dosing follows a pretty consistent pattern across the community, and this guide covers all of it, how much, how often, which route, how to mix a vial, and how long to run it.
Putting it together took more digging than expected. That meant reading the actual rat and dog studies behind the numbers everyone repeats, checking vendor reconstitution math by hand instead of trusting someone else’s chart, and confirming the legal status as it stands today rather than recycling whatever was accurate a year ago.
⚡ Quick Answer
Most people take 250 to 500 mcg of BPC-157 daily, subcutaneous, split into one or two shots, for 4 to 8 weeks. Injecting close to an injury is common practice. A 5mg vial mixed with 2mL of bacteriostatic water gives you 2.5mg/mL, which works out to 20 doses at 250mcg each, about 10 days of twice-daily use. Full breakdown by goal, route, and vial size below.
Our pick for sourcing it is Everest Peptides, trusted by BrainFlow readers, with COAs posted right on the product page. It runs $49.99, currently on sale for $39.99, and code BRAINFLOW takes another 10 percent off that, down to about $35.99.
Route by Route
Route matters more than people think, and it comes down to where you want the effect to happen. Injection gets BPC-157 into the bloodstream directly, which is why it is the default choice for systemic goals, tendon and ligament healing, joint issues, muscle recovery, anything happening somewhere other than the digestive tract itself.
Subcutaneous injection is the dominant route, matching nearly every study and nearly every community protocol. Injecting close to the site of injury, rather than only into the abdomen, is common practice when there is a specific area to target.
Oral takes a different path. The peptide survives gastric acid for well over 24 hours, unusual and part of why it is stable enough to swallow in the first place. What has never been measured is how much of an oral dose crosses into systemic circulation afterward.
Practically, that means oral makes the most sense when the digestive tract itself is the goal, since the peptide is already sitting right where it needs to act, and less sense if you are chasing a tendon or joint outcome that requires it to travel somewhere else in the body first.
Capsules commonly run 200 to 250 mcg, and people often dose oral slightly higher than injectable to account for whatever gets lost along the way. If gut or digestive support is the actual goal, Infiniwell’s Rapid Pro is built specifically for oral use, and first-time customers save 15 percent with code WELCOME15.
Nasal spray and topical use show up in smaller pockets of the community, mostly for localized skin healing or targeted delivery. Dosing for both typically mirrors the injectable numbers.
Trusted by BrainFlow Readers
Everest Peptides BPC-157, 10mg
It’s the source we trust for BPC-157. Every batch is third-party tested for purity, heavy metals, and endotoxins, with the COA posted right on the product page, no digging required. $49.99 regular, on sale now for $39.99, and code BRAINFLOW knocks another 10 percent off that.
Shop BPC-157 → Save 10%Use code BRAINFLOW for 10% off. Sold for research use only.
Dosing by Goal
Gut and digestive use
This is where BPC-157’s reputation started, since it was originally studied as a gut-protective compound. Common protocols run 250 to 500 mcg daily, oral or subcutaneous, for 4 to 6 weeks.
Tendon, ligament, and joint injury
Doses here tend to run at the higher end, 250 to 500 mcg daily, often split into two shots, for a longer stretch than other uses, commonly 6 to 12 weeks given how slowly connective tissue heals. This is also where injecting near the injury shows up most often.
Muscle strain and recovery
Similar numbers to tendon work, usually 250 mcg twice daily, for a shorter window, 4 to 6 weeks.
General inflammation and systemic use
People using BPC-157 as a broader anti-inflammatory tool rather than targeting one injury tend to land on the lowest common number, around 250 mcg once daily.
Wound and skin healing
Less common as a standalone goal. When it comes up, doses mirror the systemic range, 250 to 500 mcg daily.
Once a Day or Twice a Day?
Both show up constantly. The case for twice daily comes from the compound’s short half-life, about 15 minutes in animal studies, so splitting the dose keeps more consistent levels across the day. The case for once daily comes from the idea that its effects last well past that window, so frequency may matter less than people assume.
Most protocols default to twice daily when targeting a specific injury, and once daily for general or maintenance use.
How Long to Run a Cycle
Running BPC-157 for a set number of weeks and then taking a break is standard practice.
- General use: around 4 weeks, sometimes run as 5 days on and 2 off
- Moderate injury: 6 to 8 weeks
- Significant tendon or ligament injury: 8 to 12 weeks
- Between cycles: a 2 to 4 week break is most common before starting again
Timing: Meals, Workouts, and Time of Day
For oral capsules, taking BPC-157 on an empty stomach is the most common approach. For injections, timing tends to follow the goal. People targeting a specific workout or injury often inject shortly before or after that activity, while people using it for general or gut-focused reasons just pick a consistent time and stick with it.
Reconstitution and Concentration Math
One milligram equals 1,000 micrograms. Concentration in milligrams per milliliter equals the vial’s total milligrams divided by however much bacteriostatic water you add. On a standard U-100 insulin syringe, 100 units equals 1 milliliter, so 10 units equals 0.1 mL.
Vials commonly come in 5mg and 10mg sizes, so here is the math for both.
A 10mg vial mixed with 4mL of water gives you 2.5 mg/mL, and 250 mcg of that lands at a clean 10 units, easy to read on an insulin syringe. Change the water and every number in the row changes with it. Everest’s BPC-157 ships as a 10mg vial, so the second table above is the one that applies if you source from them.
The mistakes that show up over and over include confusing the vial’s total milligrams with a single dose, mixing up milligrams and micrograms, assuming a syringe unit means the same amount at any concentration, and skipping refrigeration on a peptide that degrades without it.
Verified Sourcing
Everest Peptides, COA on Every Product Page
No need to dig for verification. Every Everest batch is independently tested for purity, heavy metals, and endotoxins, with the certificate posted directly on the product page. 10mg vial, $49.99 regular, $39.99 on sale, about $35.99 with code BRAINFLOW.
Get BPC-157 → Save 10%Code BRAINFLOW takes 10% off the sale price. Sold for research use only.
What Happens If You Take Too Much, or Miss a Dose
Animal studies have not identified a dose that causes serious harm, and a 2021 safety review found the compound well tolerated across a wide dose range in preclinical work. The only published human dosing data comes from a 2025 pilot study that gave two adults an IV infusion, 10mg on day one and 20mg on day two, considerably higher than any typical subcutaneous protocol. Both tolerated it without adverse effects.
Missing a dose has no documented consequence beyond simply missing that day’s dose. The common-sense approach is picking back up at the next scheduled time rather than doubling up to compensate.
- Injection site irritation: the most commonly reported issue, usually resolved by rotating sites
- Lightheadedness: reported occasionally, mechanism unclear
- Product quality: the real risk with any research-market vial is what is really in it
Current Legal Status in 2026
BPC-157 is not FDA-approved for any indication. It was removed from the FDA’s 503A Category 2 bulk substances list in April 2026, following withdrawn nominations rather than a new safety concern, but it was not moved to the approved Category 1 list either.
In July 2026, the FDA’s Pharmacy Compounding Advisory Committee voted 8 to 6, with one abstention, to recommend BPC-157 for that approved compounding list. That vote is a recommendation, not a rule. As of this writing, the FDA has taken no formal action, and compounding pharmacies still cannot legally prepare it. Treat any claim that this vote already legalized BPC-157 as premature.
It remains sold as a research chemical, not a supplement. Athletes should know it is prohibited at all times under the World Anti-Doping Agency’s S0 category.
Stacking With TB-500 and Other Peptides
BPC-157 and TB-500 get combined constantly enough that vendors sell them premixed. The usual logic is that they work through different repair pathways and complement each other. Ratios discussed most often run from 1:1 up to 1:5 favoring TB-500, and premixed blends commonly show up as 10mg total (5mg of each) or 20mg total.
For a full breakdown of this exact combination, see our Wolverine stack guide. Beyond TB-500, a few other combinations come up regularly. GHK-Cu gets paired in for skin and wound work, since it targets tissue remodeling from a different angle. KPV shows up in gut-focused blends alongside BPC-157 for people specifically targeting digestive inflammation.
Outside the peptide world, collagen and vitamin C get mentioned often for connective tissue work, on the logic that BPC-157 supports the repair signal while collagen and vitamin C supply the raw material the body rebuilds tendons and ligaments from. None of these combinations have been studied together in any formal way. They are common-sense pairings people discuss, not proven protocols.
What People Report
250 to 300 mcg once daily is the single most commonly reported real-world dose across forums and community discussion, with a meaningful share running twice daily instead. Reports skew toward tendon pain and gut symptoms improving over several weeks, typically somewhere in the 2 to 4 week range before people say they noticed a real difference, though plenty of people also report no noticeable change at all.
The most repeated complaints are injection site irritation, especially with repeated injections in the same small area, and doubts about product purity from unverified sellers, which is the recurring theme behind why sourcing and COAs matter as much as the dose itself. The most repeated confusion is milligrams versus micrograms, followed closely by whether injecting near an injury does anything extra over injecting anywhere else, a question this guide cannot fully answer since nobody has tested it directly.
Where to Buy BPC-157
Sourcing matters as much as the math. Buy only from a vendor that publishes real third-party certificates of analysis, not just a purity percentage with nothing to back it up.
For injectable BPC-157, our pick is Everest Peptides. Every batch is tested for purity, heavy metals, and endotoxins, and the COA is posted directly on the product page rather than buried somewhere you have to request it. The 10mg vial runs $49.99, currently on sale for $39.99, and code BRAINFLOW takes another 10 percent off, landing around $35.99. For oral, Infiniwell’s Rapid Pro is our pick, 15 percent off first orders with code WELCOME15.
The Research Behind These Numbers
Everything above reflects what is commonly used across the BPC-157 community and vendor world. Worth knowing plainly, no human clinical trial has ever established an official dose. Here is what the actual research shows, and does not show.
The tendon and ligament dosing convention traces back to rat studies on Achilles tendon injury, where researchers surgically cut the tendon and then gave BPC-157 at doses around 10 mcg per kilogram, tracking how well the tissue healed compared to untreated animals. The gut and digestive convention comes from a longer history of similar rat work on stomach ulcers and inflammatory bowel models, which is also where BPC-157 got its original reputation as a gastric protective compound before anyone was using it for tendons at all.
The pharmacokinetic side comes from a 2022 study in rats and dogs that tracked exactly how the compound moves through the body, measuring an average IV half-life of about 15 minutes and looking at how much survives after intramuscular injection. That study is the source for nearly every half-life claim you will see repeated online.
On the human side, there is exactly one published dosing study, and it involved two people. A 2025 pilot gave two adults an escalating IV dose over two days to check basic safety and how fast the compound cleared their blood. It was not designed to test whether any dose works for anything, only whether it was safe to give at all. It was.
Scaled directly from the animal dose using standard dose-conversion math, the 10 mcg/kg rat dose works out to roughly 100 to 160 mcg for most adults, lower than the 250 to 500 mcg range everyone ends up using. That gap does not mean the common protocol is wrong. It means it is convention layered on top of animal data, not a number any human trial ever tested directly, and it is worth knowing the difference between the two.
BPC-157 Dosage FAQ
How much BPC-157 should I take per day?
Most people run 250 to 500 mcg daily, subcutaneous, split into one or two shots. See the dosing-by-goal breakdown above for specifics based on what you are targeting.
Should I take it once or twice a day?
Twice daily is more common for anyone targeting a specific injury. Once daily works fine for general or maintenance use.
Is it better to inject near the injury?
Yes, that is standard practice, especially for tendon and ligament work, on the idea that local concentration helps healing right at that site.
Should I use oral or injectable BPC-157?
It depends on the goal. Injectable is the better fit for tendon, joint, or muscle recovery, since it reaches the bloodstream directly. Oral makes more sense for gut and digestive goals, since the peptide is already where it needs to act.
How do I reconstitute a 5mg or 10mg vial?
Divide the vial’s total milligrams by the milliliters of bacteriostatic water you add to get the concentration. See the reconstitution tables above for worked examples on both common vial sizes.
How many units is 250 mcg?
It depends on your concentration. At 2.5 mg/mL, 250 mcg is 10 units. At 5 mg/mL, it is 5 units. Calculate from your own reconstitution rather than borrowing a number mixed at a different ratio.
How long should a cycle last?
4 weeks for general use, up to 8 to 12 weeks for significant tendon or ligament injuries, with a 2 to 4 week break between cycles.
What is BPC-157’s half-life?
About 15 minutes in the one formal pharmacokinetic study, done in rats and dogs. No human half-life has been published.
Is BPC-157 legal in 2026?
It is not FDA-approved, and despite a July 2026 advisory committee vote recommending it for compounding, the FDA has not yet acted on that recommendation. It remains sold only as a research chemical and is prohibited for athletes under WADA’s S0 category.
Can I stack it with TB-500?
Yes, it is one of the most common peptide combinations, usually at ratios between 1:1 and 1:5 favoring TB-500.
Where can I buy BPC-157?
We recommend Everest Peptides for injectable, tested for purity, heavy metals, and endotoxins with the COA posted on the page. 10mg is $49.99, on sale for $39.99, about $35.99 with code BRAINFLOW. For oral, we recommend Infiniwell’s Rapid Pro.
The Bottom Line
250 to 500 mcg, subcutaneous, once or twice daily, for 4 to 8 weeks depending on what you are targeting, that is the protocol nearly everyone lands on, and the reconstitution tables above give you the exact math for a 5mg or 10mg vial. Use the goal-based breakdown to fine-tune length and frequency for your specific situation, and source it from somewhere that shows you the certificate of analysis, not just claims one exists.
Sources
- Sikirić P, et al. “Stable gastric pentadecapeptide BPC 157.” Current Pharmaceutical Design, 2011. PubMed
- Krivic A, et al. “Achilles detachment in rat and stable gastric pentadecapeptide BPC 157.” Journal of Orthopaedic Research, 2006. PubMed
- Chang CH, et al. “The promoting effect of pentadecapeptide BPC 157 on tendon healing.” Journal of Applied Physiology, 2011. PubMed
- Wang J, et al. “Gastric pentadecapeptide BPC 157 and TNF-alpha modulation.” Gut and Liver review, 2020. PubMed
- Xu C, Sun L, Ren F, et al. “Pharmacokinetics, distribution, metabolism, and excretion of BPC157 in rats and dogs.” Frontiers in Pharmacology, 2022. PMC
- Seiwerth S, et al. “BPC 157 and standard angiogenic growth factors.” Preclinical safety review, 2021. PMC
- Lee E, Burgess K. “Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study.” Alternative Therapies in Health and Medicine, 2025. PubMed
- Nair AB, Jacob S. “A simple practice guide for dose conversion between animals and human.” Journal of Basic and Clinical Pharmacy, 2016. PMC
- U.S. Food and Drug Administration, Pharmacy Compounding Advisory Committee meeting record, July 2026.
- World Anti-Doping Agency, Prohibited List, S0 category, 2026.
BPC-157 is not FDA-approved for any indication. All information here is for educational and research purposes only and is not medical advice.
BPC-157 is sold as a research compound for laboratory use only. Consult a qualified healthcare provider before beginning any protocol.
This article contains affiliate links. BrainFlow may earn a commission on qualifying purchases at no additional cost to the reader. We only recommend sources we trust.
